| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |